Drugs / KSR-001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05017870 | Dec 2018 → Jun 2019 | dry eye syndrome | Kukje Pharma | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KSR-001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05017870 ↗ |